Fortune 500 Drug & Device Development Company Implements SafeBreach to Take the Guesswork Out of Validation
Fortune 500 Drug & Device Development Company Implements SafeBreach to Take the Guesswork Out of Validation
5 PagesSafeBreach software eliminated guesswork in security validation for a Fortune 500 drug and device development company in life sciences, where protecting clinical trial data demanded constant vigilance. Struggling to assess diverse control effectiveness, the team implemented SafeBreach to safely and automatically execute continuous attack simulations across their architecture. This generated data-driven intelligence to pinpoint and address critical vulnerabilities, ensuring robust safeguards for sensitive records, proactive remediation, and reliable defense against threats in high-stakes operations.
